What's new for DVT prophylaxis for the medically ill

Disease-a-Month

Volumn 51, Issue 2-3, 2005, Pages 194-199

  Ageno, Walter ^a   Turpie, Alexander G G ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; WARFARIN;

BLEEDING; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; PROPHYLAXIS; REVIEW; VENOUS THROMBOEMBOLISM;

EID: 19344376608     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2005.03.015     Document Type: Article

References (21)

1. D.A. Sandler, J.F. Martin Autopsy proven pulmonary embolism in hospital patients are we detecting enough deep vein thrombosis? J R Soc Med 82 1989 203 205
2. S.Z. Goldhaber, D.D. Savage, R.J. Garrison, W.P. Castelli Risk factors for pulmonary embolism the Framingham study Am J Med 74 1983 1023 1028
3. F.A. Anderson, H.B. Wheeler, R.J. Goldberg A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study Arch Intern Med 151 1991 933 938
4. B. Lindblad, N.H. Sternby, D. Bergqvist Incidence of venous thromboembolism verified by necropsy over 30 years BMJ 302 1991 709 711
5. T.P. Baglin, K. White, A. Charles Fatal pulmonary embolism in hospitalised medical patients J Clin Pathol 50 1997 609 610
6. J. Bouthier The venous thrombotic risk in nonsurgical patients Drugs 52 suppl 1996 16 29
7. S.Z. Goldhaber, K. Dunn, R.C. MacDougall New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment Chest 118 2000 1680 1684
8. M. Monreal, A.K. Kakkar, J.A. Caprini The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE Registry J Thromb Haemost 2 11 2004 1892 1898
9. P. Mismetti, S. Laporte-Simitsidis, B. Tardy Prevention of venous thromboembolism in internal medicine with unfractionated or low molecular weight heparins a meta-analysis of randomised clinical trials Thromb Haemost 83 2000 14 19
10. M.M. Samama, A.T. Cohen, J.Y. Darmon A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients N Engl J Med 341 1999 793 800
11. A. Leizorovicz, A.T. Cohen, A.G.G. Turpie Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 7 2004 874 879
12. A.G.G. Turpie, K.A. Bauer, B.I. Eriksson Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery Arch Intern Med 162 2002 1833 1840
13. A.T. Cohen, B. Davidson, A.S. Gallus Fondaparinux for the prevention of VTE in acutely ill medical patients Blood 102 11 2003 15a
14. W.H. Geerts, G.F. Pineo, J.A. Heit Prevention of venous thromboembolism Chest 126 2004 338S 400S
15. W. Ageno, A. Squizzato, F. Ambrosini Thrombosis prophylaxis in medical patients a retrospective review of clinical practice patterns Haematologica 87 2002 746 750
16. F.A. Anderson Jr, V.F. Tapson, H. Decousus IMPROVE, a multinational observational cohort study of practices in prevention of venous thromboembolism in acutely ill medical patients a comparison with clinical study patient populations Blood 102 2003 1146 (abstract)
17. S.A. Rahim, A. Panju, M. Pai Venous thromboembolism prophylaxis in medical inpatients a retrospective chart review Thromb Res 111 2003 215 219
18. A.K. Kakkar, B.L. Davidson, S.K. Haas Compliance with recommended prophylaxis for venous thromboembolism improving the use and rate of uptake of clinical practice guidelines J Thromb Haemost 2 2004 221 227
19. R. Alikhan, A.T. Cohen, S. Combe Prevention of venous thromboembolism in medical patients with enoxaparin a subgroup analysis of the MEDENOX study Blood Coagul Fibrinolysis 4 4 2003 341 346
20. M.M. Samama An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. The Sirius Study Arch Intern Med 160 2000 3415 3420
21. J.A. Heit, M.D. Silverstein, D.N. Mohr Risk factors for deep vein thrombosis and pulmonary embolism Arch Intern Med 160 2000 809 815